Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday.

Shares of Hewlett Packard Enterprise Company HPE shares fell sharply in pre-market trading on Tuesday.

HP might be on the verge of acquiring Juniper Networks JNPR, in a deal possibly worth around $13 billion. The announcement could be made as early as this week, according to The Wall Street Journal.

Hewlett Packard Enterprise shares dipped 8.5% to $16.21 in pre-market trading.

Here are some big stocks recording losses in today’s pre-market trading session.

• Grifols, S.A. GRFS shares dipped 46.3% to $5.98 in pre-market trading.
• CyberArk Software Ltd. CYBR shares fell 6.5% to $203.93 in pre-market trading. CyberArk is expected to report its fourth quarter and year end 2023 financial results on Feb. 8, 2024.
• Summit Therapeutics Inc. SMMT fell 5.7% to $2.80 in pre-market trading after jumping 16% on Monday. Summit Therapeutics announced updated Phase II data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference.
• Nkarta, Inc. NKTX shares declined 5.4% to $10.15 in pre-market trading. Nkarta shares jumped 77% on Monday after the company announced an updated corporate presentation to reflect certain business and strategic updates.
• Hologic, Inc. HOLX shares declined 5% to $67.76 in pre-market trading. Hologic announced preliminary revenue results for the first quarter, expecting revenue of $1.013 billion.
• Microchip Technology Incorporated MCHP shares declined 4.3% to $81.98 in pre-market trading after the company said it sees preliminary third-quarter revenue down roughly 22% sequentially compared to its prior guidance of down 15% to 20%.
• Prothena Corporation plc PRTA shares fell 4.2% to $33.79 in pre-market trading. Prothena shares fell 13% on Monday after the company provided a business update on portfolio programs.
• Heron Therapeutics, Inc. HRTX shares declined 3.8% to $2.01 in pre-market trading after jumping 18% on Monday. Heron Therapeutics announced a five-year distribution partnership with CrossLink Life Sciences to expand promotional effort for ZYNRELEF.

Now Read This: TD SYNNEX, Albertsons And 3 Stocks To Watch Heading Into Tuesday

Don’t forget to check out our premarket coverage here